Anticoagulation for Aortic Bioprosthesis (ANTIPRO)

PHASE4CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

December 31, 2019

Conditions

Aortic Valve StenosisAortic Valve DiseaseAortic Valve InsufficiencyAortic Valve Regurgitation

Interventions

DRUG

Warfarin

Oral anticoagulation

DRUG

Aspirin

Antiplatelet treatment

Trial Locations (2)

Centro Cardiovascular Universitario, Montevideo

Instituto Nacional de Cirugia Cardiaca, Montevideo

All Listed Sponsors

collaborator

Universidad de la Republica

OTHER

lead

Instituto Nacional de Cirugia Cardiaca, Uruguay

OTHER

NCT03807921 - Anticoagulation for Aortic Bioprosthesis (ANTIPRO) | Biotech Hunter | Biotech Hunter